Emerging Topics in Heart Failure: New Paradigms in Cardiac Amyloidosis.
Marcos Vinicius SimõesSílvia Marinho Martins AlvesFábio FernandesOtávio Rizzi Coelho-FilhoSandrigo ManginiPublished in: Arquivos brasileiros de cardiologia (2020)
Recent evidence suggests cardiac amyloidosis (CA) is a mostly underdiagnosed condition, particularly in the transthyretin-mediated form, and is a frequent cause of heart failure with preserved ejection fraction (HFpEF) in the elderly. New paradigms about CA also involve the development of disease-modifying specific therapies. This article summarizes these new concepts.